Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : BXRX    save search

Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
Published: 2023-01-24 (Crawled : 14:00) - biospace.com/
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: 101.98% H: 12.58% C: -31.86%

bx1000 for trial positive
Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030
Published: 2022-12-30 (Crawled : 14:00) - prnewswire.com
SILO | $2.5275 -1.27% 2.87% 54K twitter stocktwits trandingview |
Finance and Insurance
| | O: 59.74% H: 0.0% C: 0.0%
NUWE | $9.24 -6.95% -7.93% 190K twitter stocktwits trandingview |
Manufacturing
| | O: -19.4% H: 0.0% C: 0.0%
KALA | $16.54 -0.66% -1.34% 89K twitter stocktwits trandingview |
Health Technology
| | O: 111.55% H: 0.0% C: 0.0%
HOTH | $3.48 -19.07% -23.92% 7.3M twitter stocktwits trandingview |
Health Technology
| | O: -13.98% H: 0.0% C: 0.0%
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: -17.27% H: 0.0% C: 0.0%

global expected market
Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery
Published: 2022-12-08 (Crawled : 14:20) - biospace.com/
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: 4.15% H: 22.51% C: 15.95%

bx1000 trial
Baudax Bio Announces Pricing of $5 Million Public Offering
Published: 2022-12-02 (Crawled : 20:00) - globenewswire.com
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

offering
Baudax Bio Announces 1-for-40 Reverse Stock Split
Published: 2022-11-30 (Crawled : 22:00) - globenewswire.com
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist


Baudax Bio to Present at the 24th Annual H.C. Wainwright Healthcare Conference
Published: 2022-09-08 (Crawled : 01:00) - biospace.com/
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: -5.27% H: 0.0% C: 0.0%

conference
Baudax Bio Announces Closing of $6.2 Million Public Offering
Published: 2022-09-01 (Crawled : 19:00) - globenewswire.com
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 5.6% C: -5.05%

offering
Baudax Bio Announces Pricing of $6.2 Million Public Offering - Aug 30, 2022
Published: 2022-08-30 (Crawled : 06:00) - biospace.com/
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: -43.34% H: 0.0% C: 0.0%

offering
Baudax Bio Announces Pricing of $6.2 Million Public Offering
Published: 2022-08-30 (Crawled : 03:00) - globenewswire.com
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: -43.34% H: 0.0% C: 0.0%

offering
Baudax Bio receives notice of allowance for U.S. Patent Application covering use of ANJESO® for the treatment of moderate to severe pain
Published: 2022-08-22 (Crawled : 14:00) - biospace.com/
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: 0.07% H: 1.81% C: -6.25%

anjeso treatment patent for application
Cosette Pharmaceuticals Appoints Rick Casten as CFO Amid Transformational Growth
Published: 2022-07-06 (Crawled : 13:00) - biospace.com/
CPB | $50.9 -0.78% 0.2% 1.8M twitter stocktwits trandingview |
Consumer Non-Durables
| | O: -0.53% H: 0.0% C: 0.0%
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: 2.86% H: 1.44% C: -1.17%

growth
Baudax Bio Announces $2.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Published: 2022-05-17 (Crawled : 00:00) - globenewswire.com
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: -28.51% H: 1.56% C: -3.81%

offering nasdaq
Alkermes plc Reports First Quarter 2022 Financial Results
Published: 2022-04-27 (Crawled : 14:20) - biospace.com/
JNJ | $163.61 0.13% 0.22% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.77% H: 0.0% C: 0.0%
BIIB A | $285.45 -2.05% -2.05% 500K twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 1.11% C: -0.33%
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: 0.67% H: 4.05% C: 3.38%
ALKS | $26.79 -1.44% -1.46% 960K twitter stocktwits trandingview |
Health Technology
| | O: 13.01% H: 2.29% C: -0.95%

results
Baudax Bio Reports 2021 Fourth Quarter and Annual Financial Results
Published: 2022-03-16 (Crawled : 12:00) - globenewswire.com
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: 3.09% H: 5.69% C: 4.19%

financial results report results
Baudax Bio to Present at the Oppenheimer 32nd Annual Healthcare Conference
Published: 2022-03-10 (Crawled : 14:00) - globenewswire.com
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: 6.98% H: 0.0% C: -2.17%

health thc conference
Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO® in Pediatric Patients Following Surgery
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: 1.27% H: 2.49% C: 1.25%

anjeso trial
Baudax Bio Regains Compliance with NASDAQ Listing Requirements
Published: 2022-03-07 (Crawled : 14:30) - biospace.com/
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: 1.74% H: 0.26% C: -9.71%

nasdaq
Baudax Bio Announces Seventh Orange Book Listable Patent for ANJESO®
Published: 2022-03-02 (Crawled : 13:30) - globenewswire.com
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.53% C: -1.58%

anjeso ces patent
Baudax Bio Announces Pricing of $10.0 Million Public Offering - Feb 25, 2022
Published: 2022-02-25 (Crawled : 09:00) - biospace.com/
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: -46.37% H: 0.0% C: 0.0%

offering ces
Baudax Bio Announces Pricing of $10.0 Million Public Offering
Published: 2022-02-25 (Crawled : 05:00) - globenewswire.com
BXRX | $3.25 -4.69% -6.07% 170K twitter stocktwits trandingview |
Health Technology
| | O: -46.37% H: 0.0% C: 0.0%

offering ces publication
Gainers vs Losers
57% 43%

Top 10 Gainers
CZOO | $0.2001 -16.63% 1864.02% 3.3M twitter stocktwits trandingview |

AVRO | $1.69 93.7% 54.08% 38M twitter stocktwits trandingview |
Health Technology

CELZ | $1.04 101.04% 50.26% 140M twitter stocktwits trandingview |

WETG | $0.65 58.54% 37.88% 27M twitter stocktwits trandingview |

GFAI | $0.5408 58.36% 36.88% 89M twitter stocktwits trandingview |

KPRX | $6.94 52.53% 34.15% 36M twitter stocktwits trandingview |
Manufacturing

PRFX | $0.7236 44.72% 30.07% 14M twitter stocktwits trandingview |
Health Technology

BJDX | $0.64 37.16% 23.51% 2.8M twitter stocktwits trandingview |

SOUN 4 | $4.63 28.61% 22.08% 62M twitter stocktwits trandingview |

THCH | $5.3 26.19% 19.69% 750K twitter stocktwits trandingview |
n/a


Your saved searches
Save your searches and get alerts when important news are released.